Degradation of thyroid hormone receptor beta 1: Existence of stable and unstable forms

Thyroid

Volumn 21, Issue 3, 2011, Pages 311-318

  Brunelle, Mylène ^a   Fayad, Tania ^a   Langlois, Marie France ^a  

^a UNIVERSITÉ DE SHERBROOKE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOHEXIMIDE; GLUTAMIC ACID; PROLINE; PROTEASOME; SERINE; THREONINE; THYROID HORMONE RECEPTOR BETA; THYROID HORMONE RECEPTOR BETA 1; UNCLASSIFIED DRUG;

ARTICLE; CELL FRACTIONATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DEGRADATION KINETICS; EMBRYO; GOLD STANDARD; HUMAN; HUMAN CELL; MOLECULAR MECHANICS; MOLECULAR STABILITY; POINT MUTATION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PROTEIN METABOLISM; PROTEIN MOTIF; PROTEIN SYNTHESIS; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

CELL NUCLEUS; ENZYME STABILITY; PROTEASOME ENDOPEPTIDASE COMPLEX; THYROID HORMONE RECEPTORS BETA;

EID: 79952436685     PISSN: 10507256     EISSN: None     Source Type: Journal    
DOI: 10.1089/thy.2009.0363     Document Type: Article

References (43)

1. Yen PM 2001 Physiological and molecular basis of thyroid hormone action. Physiol Rev 81:1097-1142. (Pubitemid 32606667)
2. Alarid ET 2006 Lives and times of nuclear receptors. Mol Endocrinol 20:1972-1981. (Pubitemid 44286698)
3. Hershko A, Ciechanover A 1998 The ubiquitin system. Annu Rev Biochem 67:425-479. (Pubitemid 28411135)
4. Collins GA, Tansey WP 2006 The proteasome: a utility tool for transcription? Curr Opin Genet Dev 16:197-202. (Pubitemid 43376068)
5. Dennis AP, O'Malley BW 2005 Rush hour at the promoter: how the ubiquitin-proteasome pathway polices the traffic flow of nuclear receptor-dependent transcription. J Steroid Biochem Mol Biol 93:139-151. (Pubitemid 40602486)
6. Kinyamu HK, Chen J, Archer TK 2005 Linking the ubiquitinproteasome pathway to chromatin remodeling/modification by nuclear receptors. J Mol Endocrinol 34:281-297. (Pubitemid 40585182)
7. Muratani M, Tansey WP 2003 How the ubiquitin-proteasome system controls transcription. Nat Rev Mol Cell Biol 4:192-201. (Pubitemid 36288041)
8. Reid G, Hubner MR, Metivier R, Brand H, Denger S, Manu D, Beaudouin J, Ellenberg J, Gannon F 2003 Cyclic, proteasome-mediated turnover of unliganded and liganded ERalpha on responsive promoters is an integral feature of estrogen signaling. Mol Cell 11:695-707. (Pubitemid 36385123)
9. Deroo BJ, Rentsch C, Sampath S, Young J, DeFranco DB, Archer TK 2002 Proteasomal inhibition enhances glucocorticoid receptor transactivation and alters its subnuclear trafficking. Mol Cell Biol 22:4113-4123. (Pubitemid 34556582)
10. Lonard DM, Nawaz Z, Smith CL, O'Malley BW 2000 The 26S proteasome is required for estrogen receptor-alpha and coactivator turnover and for efficient estrogen receptoralpha transactivation. Mol Cell 5:939-948.
11. Samuels HH, Stanley F, Shapiro LE 1976 Dose-dependent depletion of nuclear receptors by L-triiodothyronine: evidence for a role in induction of growth hormone synthesis in cultured GH1 cells. Proc Natl Acad Sci USA 73:3877-3881.
12. Raaka BM, Samuels HH 1981 Regulation of thyroid hormone nuclear receptor levels in GH1 cells by 3, 5, 3'-triiodo-L-thyronine. Use of dense amino acid labeling to determine the influence of hormone on the receptor half-life and the rate of appearance of newly synthesized receptor. J Biol Chem 256:6883-6889.
13. Dace A, Zhao L, Park KS, Furuno T, Takamura N, Nakanishi M, West BL, Hanover JA, Cheng S 2000 Hormone binding induces rapid proteasome-mediated degradation of thyroid hormone receptors. Proc Natl Acad Sci USA 97:8985-8990. (Pubitemid 30626660)
14. Kenessey A, Ojamaa K 2005 Ligand-mediated decrease of thyroid hormone receptor-alpha1 in cardiomyocytes by proteosome-dependent degradation and altered mRNA stability. Am J Physiol Heart Circ Physiol 288: H813-H821. (Pubitemid 40139667)
15. Tansey WP. Ultimate mammalian cell pulse-chase. Available at www.ihcworld.com/-protocols/lab-protocols/tansey-labprotocols.htm, accessed May 13, 2010.
16. Salghetti SE, Kim SY, Tansey WP 1999 Destruction of Myc by ubiquitin-mediated proteolysis: cancer-associated and transforming mutations stabilize Myc. EMBO J 18:717-726. (Pubitemid 29057256)
17. Baumann CT, Maruvada P, Hager GL, Yen PM 2001 Nuclear cytoplasmic shuttling by thyroid hormone receptors. multiple protein interactions are required for nuclear retention. J Biol Chem 276:11237-11245. (Pubitemid 38089310)
18. Zhu XG, Hanover JA, Hager GL, Cheng SY 1998 Hormoneinduced translocation of thyroid hormone receptors in living cells visualized using a receptor green fluorescent protein chimera. J Biol Chem 273:27058-27063. (Pubitemid 28500409)
19. Tansey WP. Ultimate mammalian denaturing IP. Available at www.ihcworld.com/-protocols/lab-protocols/tansey-labprotocols.htm, accessed May 13, 2010.
20. Wysocka J, Reilly PT, Herr W 2001 Loss of HCF-1-chromatin association precedes temperature-induced growth arrest of tsBN67 cells. Mol Cell Biol 21:3820-3829. (Pubitemid 32466993)
21. Battista MC, Roberge C, Otis M, Gallo-Payet N 2007 Seladin-1 expression in rat adrenal gland: effect of adrenocorticotropic hormone treatment. J Endocrinol 192:53-66. (Pubitemid 46444395)
22. Vlcek S, Dechat T, Foisner R 2001 Nuclear envelope and nuclear matrix: interactions and dynamics. Cell Mol Life Sci 58:1758-1765. (Pubitemid 33108766)
23. Tsurimoto T 1999 PCNA binding proteins. Front Biosci 4: D849-D858.
24. Rechsteiner M, Rogers SW 1996 PEST sequences and regulation by proteolysis. Trends Biochem Sci 21:267-271. (Pubitemid 26228278)
25. Tworkowski KA, Salghetti SE, Tansey WP 2002 Stable and unstable pools of Myc protein exist in human cells. Oncogene 21:8515-8520. (Pubitemid 36054893)
26. Ting YT, Bhat MK, Wong R, Cheng S 1997 Tissue-specific stabilization of the thyroid hormone beta1 nuclear receptor by phosphorylation. J Biol Chem 272:4129-4134. (Pubitemid 27078478)
27. Chen SL, Chang YJ, Wu YH, Lin KH 2003 Mitogen-activated protein kinases potentiate thyroid hormone receptor transcriptional activity by stabilizing its protein. Endocrinology 144:1407-1419. (Pubitemid 36428483)
28. Mitsuhashi T, Uchimura H, Takaku F 1987 n-Butyrate increases the level of thyroid hormone nuclear receptor in nonpituitary cultured cells. J Biol Chem 262:3993-3999.
29. Samuels HH, Stanley F, Casanova J, Shao TC 1980 Thyroid hormone nuclear receptor levels are influenced by the acetylation of chromatin-associated proteins. J Biol Chem 255:2499-2508. (Pubitemid 10036050)
30. Liu Y, Xia X, Fondell JD, Yen PM 2006 Thyroid hormoneregulated target genes have distinct patterns of coactivator recruitment and histone acetylation. Mol Endocrinol 20:483-490. (Pubitemid 43291203)
31. Jacoby DB, Engle JA, Towle HC 1987 Induction of a rapidly responsive hepatic gene product by thyroid hormone requires ongoing protein synthesis. Mol Cell Biol 7:1352-1357. (Pubitemid 17045222)
32. Stenoien DL, Mancini MG, Patel K, Allegretto EA, Smith CL, Mancini MA 2000 Subnuclear trafficking of estrogen receptor-alpha and steroid receptor coactivator-1. Mol Endocrinol 14:518-534. (Pubitemid 32260520)
33. van Steensel B, Jenster G, Damm K, Brinkmann AO, van Driel R 1995 Domains of the human androgen receptor and glucocorticoid receptor involved in binding to the nuclear matrix. J Cell Biochem 57:465-478.
34. Graham JD, Hanson AR, Croft AJ, Fox AH, Clarke CL 2009 Nuclear matrix binding is critical for progesterone receptor movement into nuclear foci. FASEB J 23:546-556.
35. Stein GS, van Wijnen AJ, Stein JL, Lian JB, Montecino M, Choi J, Zaidi K, Javed A 2000 Intranuclear trafficking of transcription factors: implications for biological control. J Cell Sci 113 (Pt 14):2527-2533. (Pubitemid 30599408)
36. Wei X, Somanathan S, Samarabandu J, Berezney R 1999 Three-dimensional visualization of transcription sites and their association with splicing factor-rich nuclear speckles. J Cell Biol 146:543-558. (Pubitemid 29388130)
37. Baumann CT, Ma H, Wolford R, Reyes JC, Maruvada P, Lim C, Yen PM, Stallcup MR, Hager GL 2001 The glucocorticoid receptor interacting protein 1 (GRIP1) localizes in discrete nuclear foci that associate with ND10 bodies and are enriched in components of the 26S proteasome. Mol Endocrinol 15:485-500. (Pubitemid 32324434)
38. Davis PJ, Davis FB, Lin HY 2008 Promotion by thyroid hormone of cytoplasm-to-nucleus shuttling of thyroid hormone receptors. Steroids 73:1013-1017.
39. Davis PJ, Shih A, Lin HY, Martino LJ, Davis FB 2000 Thyroxine promotes association of mitogen-activated protein kinase and nuclear thyroid hormone receptor (TR) and causes serine phosphorylation of TR. J Biol Chem 275:38032-38039. (Pubitemid 32004926)
40. Ting YT, Cheng SY 1997 Hormone-activated phosphorylation of human beta1 thyroid hormone nuclear receptor. Thyroid 7:463-469.
41. Lin KH, Ashizawa K, Cheng SY 1992 Phosphorylation stimulates the transcriptional activity of the human beta 1 thyroid hormone nuclear receptor. Proc Natl Acad Sci USA 89:7737-7741.
42. Moraitis AN, Giguere V 2003 The co-repressor hairless protects RORalpha orphan nuclear receptor from proteasome-mediated degradation. J Biol Chem 278:52511-52518. (Pubitemid 38035845)
43. Boudjelal M, Wang Z, Voorhees JJ, Fisher GJ 2000 Ubiquitin/proteasome pathway regulates levels of retinoic acid receptor gamma and retinoid X receptor alpha in human keratinocytes. Cancer Res 60:2247-2252. (Pubitemid 30225190)